𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab

✍ Scribed by E. Montagna; G. Cancello; D. D’Agostino; R. Lauria; V. Forestieri; A. Esposito; L. Silvestro; A. Accurso; S. De Placido; M. De Laurentiis

Publisher
Springer
Year
2008
Tongue
English
Weight
234 KB
Volume
63
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Central nervous system progression of me
Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel
✍ Ronnie J. Freilich; Andrew D. Seidman; Dr. Lisa M. Deangelis 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB 👁 2 views

Background. The possibility of tumor sanctuary sites in the central nervous system (CNS) of patients receiving paclitaxel has been suggested by laboratory data identifying low concentrations of drug in the brain and cerebrospinal fluid (CSF) of rats. Methods. The pattern of disease progression in p

The risk of central nervous system metas
The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma
✍ Rose Lai; Chau T. Dang; Mark G. Malkin; Lauren E. Abrey 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views

## Abstract ## BACKGROUND Trastuzumab, which is a large monoclonal antibody that is efficacious in the treatment of patients with HER‐2/__neu__‐overexpressing, metastatic breast carcinoma, does not penetrate the blood‐brain barrier and, thus, may allow the brain to become a sanctuary site for micr